A semiautomated measure of whole-brain atrophy in multiple sclerosis

Journal of the Neurological Sciences

Volumn 208, Issue 1-2, 2003, Pages 57-65

  Bermel, Robert A ^a,b   Sharma, Jitendra ^a,b   Tjoa, Christopher W ^a,b   Puli, Srinivas R ^a,b   Bakshi, Rohit ^a,b,c,d  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Department of Neurology ^*  (United States)

^d GATES VASCULAR INSTITUTE AT KALEIDA HEALTH   (United States)

Author keywords

Atrophy; Brain parenchymal fraction; Disability evaluation; MRI; Multiple sclerosis; T1 black holes; T2 lesions

Indexed keywords

ACCURACY; ADULT; ARTICLE; BRAIN; BRAIN ATROPHY; BRAIN THIRD VENTRICLE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PATHOLOGY; PRIORITY JOURNAL;

EID: 0037445614     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00425-2     Document Type: Article

References (39)

1. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult. Scler. 5:1999;283-286.
2. van Walderveen M.A., Kamphorst W., Scheltens P.et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 50:1998;1282-1288.
3. van Waesberghe J.H., van Walderveen M.A., Castelijns J.A.et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am. J. Neuroradiol. 19:1998;675-683.
4. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
5. Filippi M., Tortorella C., Rovaris M. Magnetic resonance imaging of multiple sclerosis. J. Neuroimaging. 12:2002;289-301.
6. Bakshi R., Miletich R.S., Kinkel P.R., Emmet M.L., Kinkel W.R. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J. Neuroimaging. 8:1998;228-234.
7. Cifelli A., Arridge M., Jezzard P.et al. Thalamic neurodegeneration in multiple sclerosis. Ann. Neurol. 52:2002;650-653.
8. Bakshi R., Dmochowski J., Shaikh Z.A., Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in brains of multiple sclerosis patients. J. Neurol. Sci. 185:2001;19-26.
9. Zivadinov R., Sepcic J., Nasuelli D.et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 70:2001;773-780.
10. Bakshi R., Czarnecki D., Shaikh Z.A.et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport. 11:2000;1153-1158.
11. Fisher E., Rudick R.A., Simon J.H.et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology. 59:2002;1412-1420.
12. Rudick R.A., Fisher E., Lee J.C., Simon J., Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology. 53:1999;1698-1704.
13. Losseff N.A., Wang L., Lai H.M.et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain. 119:1996;2009-2019.
14. Bakshi R., Benedict R.H., Bermel R.A., Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and clinical findings. J. Neuroimaging. 11:2001;129-136.
15. Comi G., Filippi M., Martinelli V.et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J. Neurol. Sci. 115:1993;S66-S73.
16. Benedict R., Bakshi R., Simon J., Priore R., Miller C., Munschauer F. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J. Neuropsychiatry Clin. Neurosci. 14:2002;44-51.
17. Bermel R., Bakshi R., Tjoa C., Puli S., Jacobs L. Bicaudate ratio as an MRI marker of brain atrophy in multiple sclerosis. Arch. Neurol. 59:2002;275-280.
18. Janardhan V., Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch. Neurol. 57:2000;1485-1491.
19. Simon J.H., Jacobs L.D., Campion M.K.et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology. 53:1999;139-148.
20. Berg D., Maurer M., Warmuth-Metz M., Rieckmann P., Becker G. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch. Neurol. 57:2000;1289-1292.
21. Brex P.A., Jenkins R., Fox N.C.et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology. 54:2000;1689-1691.
22. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology. 46:1996;907-911.
23. Bakshi R., Caruthers S.D., Janardhan V., Wasay M. Intraventricular CSF pulsation artifact on fast fluid-attenuated inversion-recovery MR images: analysis of 100 consecutive normal studies. AJNR Am. J. Neuroradiol. 21:2000;503-508.
24. Bakshi R., Benedict R.H., Bermel R.A.et al. T2 hypointensity in the deep gray matter of MS patients: a quantitative magnetic resonance imaging study. Arch. Neurol. 59:2002;62-68.
25. Bakshi R., Ariyaratana S., Benedict R.H.B., Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch. Neurol. 58:2001;742-748.
26. Drayer B., Burger P., Hurwitz B., Dawson D., Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am. J. Roentgenol. 149:1987;357-363.
27. Bakshi R., Shaikh Z.A., Janardhan V. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. NeuroReport. 11:2000;15-21.
28. Paolillo A., Pozzilli C., Gasperini C.et al. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J. Neurol. Sci. 174:2000;85-91.
29. Ge Y., Grossman R.I., Udupa J.K.et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology. 214:2000;665-670.
30. Filippi M., Rovaris M., Iannucci G., Mennea S., Sormani M.P., Comi G. Whole brain volume changes in patients with progressive MS treated with cladribine. Neurology. 55:2000;1714-1718.
31. Luks T.L., Goodkin D.E., Nelson S.J.et al. A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis. Multiple Sclerosis. 6:2000;332-337.
32. Turner B., Ramli N., Blumhardt L.D., Jaspan T. Ventricular enlargement in multiple sclerosis: a comparison of three-dimensional and linear MRI estimates. Neuroradiology. 43:2001;608-614.
33. Leist T.P., Gobbini M.I., Frank J.A., McFarland H.F. Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. Arch. Neurol. 58:2001;57-60.
34. Zivadinov R., Zorzon M. Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. J. Neuroimaging. 12:2002;302-309.
35. Simon J.H., Kinkel R.P., Jacobs L., Bub L., Simonian N. A Wallerian degeneration pattern in patients at risk for MS. Neurology. 54:2000;1155-1160.
36. Gutteridge J.M.C. Iron and oxygen radicals in brain. Ann. Neurol. 1992;S16-S21.
37. Qian Z.M., Shen X. Brain iron transport and neurodegeneration. Trends Mol. Med. 7:2001;103-108.
38. Bakshi R., Puli S.R., Tjoa C.W.et al. Gray matter T2 hypointensity in multiple sclerosis: a 2-year longitudinal clinical-MRI study of 79 patients. (abstract) Neurology. 58(Suppl. 3):2002;A154.
39. Bermel R.A., Innus M.D., Bakshi R. Selective caudate atrophy in multiple sclerosis: a three-dimensional MRI parcellation study. (abstract) Neurology. 58(Suppl. 3):2002;A154.